These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 5396104)
1. [Ballistocardiography in patients with diffuse toxic goiter during I-131 treatment]. Dozorets IuL; Bogdanovich GI; Seleznev LE Med Radiol (Mosk); 1969 Aug; 14(8):41-4. PubMed ID: 5396104 [No Abstract] [Full Text] [Related]
2. [Changes in the hemodynamics of patients with toxic goiter following treatment with radioactive iodine (according to radiocardiographic findings)]. Katsevman AE Med Radiol (Mosk); 1971 Nov; 16(11):36-40. PubMed ID: 4950000 [No Abstract] [Full Text] [Related]
3. [Dynamics of serum lipid changes in patients with diffuse toxic goiter during treatment with I-131]. Slukhaĭ IuF Med Radiol (Mosk); 1967 May; 12(5):67-9. PubMed ID: 5633311 [No Abstract] [Full Text] [Related]
4. [Radioactive iodine treatment of patients with relapsing toxic goiter]. Iaroslavtsev SA Klin Med (Mosk); 1968 Sep; 46(9):106-10. PubMed ID: 5756042 [No Abstract] [Full Text] [Related]
5. [Myocardial function in patients with toxic goiter as judged by electro- ballistocardiographic and electrokymographic findings]. Sedov KR; Kobelevskaia ZS Sov Med; 1972 Aug; 35(8):154-5. PubMed ID: 4677744 [No Abstract] [Full Text] [Related]
6. [Functional condition of the liver in patients with diffuse toxic goiter before and after treatment by I-131]. Siesivieva VG; Shlevkov BA; Belousova ND Med Radiol (Mosk); 1966 May; 11(5):21-7. PubMed ID: 6014327 [No Abstract] [Full Text] [Related]
7. [Megakaryocytopoiesis and thrombocytopoiesis in patients with diffuse toxic goiter during the period of treatment with I-131]. Piksanov ON; Bykhovskaia AM Med Radiol (Mosk); 1967 Jan; 12(1):82-5. PubMed ID: 5633100 [No Abstract] [Full Text] [Related]
8. [Changes in the content of electrolytes under the effect of radioiodine therapy of patients with diffuse toxic goiter in association with a severe form of thyrotoxicosis]. Lipets AI; Dozorets IL Med Radiol (Mosk); 1971 Sep; 16(9):23-6. PubMed ID: 5172424 [No Abstract] [Full Text] [Related]
9. [Remote results of the treatment of patients with toxic goiter by radioactive iodine (I-131)]. Petrova MM; Kurbatova LI Probl Endokrinol Gormonoter; 1965; 11(3):52-6. PubMed ID: 5898801 [No Abstract] [Full Text] [Related]
15. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter. Burgos FL; Micames C; Rivera JV Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791 [No Abstract] [Full Text] [Related]
16. [Use of thyrostatic preparations to reduce the radioresistance of toxic goiter during radioiodine treatment]. Livergant IuE; Suslina NG Med Radiol (Mosk); 1968 Jul; 13(7):9-11. PubMed ID: 4190228 [No Abstract] [Full Text] [Related]
19. [Treatment of hyperthyroidism in Grave's disease with low doses of radioactive iodine]. Wils JA; Kloppenborg PW Ned Tijdschr Geneeskd; 1971 Apr; 115(15):657-62. PubMed ID: 5108052 [No Abstract] [Full Text] [Related]
20. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter. Prendergast JJ; Miller JM Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196 [No Abstract] [Full Text] [Related] [Next] [New Search]